Roche launches hostile bid for Genentech

Swiss drugmaker Roche Holding launched a hostile bid for Genentech on Friday and lowered its offer for the remaining 44 percent of the U.S. biotechnology company it does not already own. Roche is now offering $86.50 (60.6 pounds) per share in cash,

Leave a Reply